Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status

Ahmad Fasseeh*, Rita Karam, Mouna Jameleddine, Mohsen George, Finn Børlum Kristensen, Abeer A. Al-Rabayah, Abdulaziz H. Alsaggabi, Maha El Rabbat, Maryam S. Alowayesh, Julia Chamova, Adham Ismail, Sherif Abaza, Zoltán Kaló

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

14 Downloads (Pure)


Introduction: Implementation of health technology assessment (HTA) is still in an early stage with some heterogeneity in the Middle East and North Africa (MENA). Our objective was to assess the current and future status of HTA implementation in the MENA region by focusing on regional commonalities. Methods: Preparatory discussions for the first ISPOR conference in the MENA region indicated some potentially generalizable trends of HTA roadmaps. To widen the perspective, a policy survey was conducted among conference participants by applying an HTA implementation scorecard. Discussion group members helped to validate key conclusions during and after the conference. Results: Health policy experts in MENA countries would like to facilitate HTA implementation and expect significant changes with some generalizable directions in 10 years compared to the current status according. HTA capacity building has to be strengthened by more graduate and postgraduate programs. Increased public budget and enhanced institutionalization are necessary success factors of HTA implementation. The scope of HTA has to be extended from pharmaceuticals to non-pharmaceutical technologies and to revision of previous policy decisions. Although cost-effectiveness with explicit threshold remains the most preferred HTA criterion, several other criteria have to be considered, maybe even by applying an explicit MCDA framework. The role of local evidence and data has to be strengthened in MENA countries, which translates to the extended use of local patient registries and payers' databases. Duplication of efforts can be reduced if international collaboration is integrated into national HTA implementation. Discussion: Our results should be viewed as an initial step in a multi-stakeholder dialogue on HTA implementation. Each MENA country should develop its context-specific HTA roadmap, as such roadmaps are not transferable without taking into account country size, economic status, public health priorities and adopted systems of health care financing.

Original languageEnglish
Article number15
JournalFrontiers in Pharmacology
Number of pages9
Publication statusPublished - 21. Feb 2020


  • economic evaluation
  • evidence-based health policy
  • health technology assessment
  • HTA implementation
  • Middle East and North Africa

Fingerprint Dive into the research topics of 'Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status'. Together they form a unique fingerprint.

Cite this